Arvind Vasudeva appointed Glenmark's COO
This article was originally published in Scrip
Executive Summary
Glenmark Pharmaceuticals of India has appointed Arvind Vasudeva as chief operating officer. Mr Vasudeva will be responsible for the company's entire branded generics business across six regions – India, Asia-Pacific, Latin America, Russia/CIS, Africa/Middle East, and Central Eastern Europe. He will be based at the company's corporate headquarters in Mumbai and report to the CEO and managing director, Glenn Saldanha. Mr Vasudeva has more than 27 years of experience in the pharmaceutical industry and was previously managing director of RPG Life Sciences.